BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35416973)

  • 1. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
    Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
    Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.
    Meites E; Gaydos CA; Hobbs MM; Kissinger P; Nyirjesy P; Schwebke JR; Secor WE; Sobel JD; Workowski KA
    Clin Infect Dis; 2015 Dec; 61 Suppl 8(Suppl 8):S837-48. PubMed ID: 26602621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichomoniasis.
    Van Gerwen OT; Opsteen SA; Graves KJ; Muzny CA
    Infect Dis Clin North Am; 2023 Jun; 37(2):245-265. PubMed ID: 37005163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.
    Meites E; Llata E; Braxton J; Schwebke JR; Bernstein KT; Pathela P; Asbel LE; Kerani RP; Mettenbrink CJ; Weinstock HS
    Sex Transm Dis; 2013 Nov; 40(11):865-9. PubMed ID: 24113409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
    Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
    Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in adherence to retesting guidelines in women with Trichomonas vaginalis infection.
    Getaneh FW; Oliveira CR; Pathy S; Sheth SS
    Am J Obstet Gynecol; 2023 Sep; 229(3):284.e1-284.e10. PubMed ID: 37393012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
    Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
    Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichomoniasis and its treatment.
    Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic aspects of trichomoniasis].
    Vukićević J; Jankicević J
    Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. British Association for Sexual Health and HIV (BASHH) United Kingdom national guideline on the management of
    Sherrard J; Pitt R; Hobbs KR; Maynard M; Cochrane E; Wilson J; Tipple C
    Int J STD AIDS; 2022 Jul; 33(8):740-750. PubMed ID: 35701863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, Natural History, Diagnosis, and Treatment of Trichomonas vaginalis in Men.
    Van Gerwen OT; Camino AF; Sharma J; Kissinger PJ; Muzny CA
    Clin Infect Dis; 2021 Sep; 73(6):1119-1124. PubMed ID: 34079999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichomoniasis: the "neglected" sexually transmitted disease.
    Meites E
    Infect Dis Clin North Am; 2013 Dec; 27(4):755-64. PubMed ID: 24275268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.
    Van der Pol B
    Clin Infect Dis; 2007 Jan; 44(1):23-5. PubMed ID: 17143810
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing.
    Schwebke J; Merriweather A; Massingale S; Scisney M; Hill C; Getman D
    Sex Transm Dis; 2018 May; 45(5):e23-e24. PubMed ID: 29465684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neglected parasitic infections in the United States: trichomoniasis.
    Secor WE; Meites E; Starr MC; Workowski KA
    Am J Trop Med Hyg; 2014 May; 90(5):800-804. PubMed ID: 24808247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity.
    Muzny CA; Van Gerwen OT; Kissinger P
    Curr Opin Infect Dis; 2020 Feb; 33(1):73-77. PubMed ID: 31789671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the epidemiology, diagnosis, and management of
    Van Gerwen OT; Muzny CA
    F1000Res; 2019; 8():. PubMed ID: 31583080
    [No Abstract]   [Full Text] [Related]  

  • 20. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.